Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Monitoring compliance to topical therapy in children and young people with uveitis

View ORCID ProfileEKY Green, O McGrath, L Steeples, J Ashworth
doi: https://doi.org/10.1101/2022.07.13.22277585
EKY Green
1Manchester Royal Eye Hospital, Oxford Road, Manchester, M13 9WL, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for EKY Green
O McGrath
1Manchester Royal Eye Hospital, Oxford Road, Manchester, M13 9WL, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Steeples
3Roche Products UK Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Ashworth
4Manchester Royal Eye Hospital, Oxford Road, Manchester, M13 9WL, Division of Evolution & Genomic Sciences, University of Manchester, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Uveitis in children and young people is a rare but potentially debilitating condition. Steroid eye drops are the first step in treatment and poor compliance may result in vision-threatening complications. This study aimed to measure compliance with prescribed eye drops prospectively and investigate reasons for non-compliance in a child-specific manner.

Methods 50 patients aged 0-18 years attending a tertiary paediatric uveitis clinic using steroid drops were recruited. Both the child or young person, and parent completed questionnaires about compliance. A subgroup had bottles of Prednisolone 1% drops weighed and dispensed at the first appointment and reweighed at follow-up. The reduction in weight was compared with expected weight change over the interval.

Results The study was completed by 31 patients. Drop errors for all eye drops were reported more than “once a week” by 13 (33.3%) children and young people, and 3 (9.7%) parents. A large proportion of parents could not recall the frequency of drops prescribed to their child (13, 40.6%). Insufficient bottle weight reduction was found in 9 (75%), although this was not associated with self-reported drop errors. Within the eye drop weighing subgroup three (25%) used <50% the expected weight of drops.

Conclusions Eye drop compliance was demonstrated to be poor by all the study outcomes in children and young people with uveitis. Self-reported compliance is unreliable in this population, as subjective responses were not supported by objective bottle weight change. Worryingly, some patients miss more than 50% of drops and may suffer worse disease control.

Clinical implications

  • What is already known on this topic

    • Poor drop compliance among children and young people with uveitis has been suggested by a previous retrospective study looking at self-reported compliance.

  • What this study adds

    • All subjective and objective metrics in this prospective study suggest steroid eye drop compliance is often poor among children with uveitis.

    • Parental administration of steroid eye drops and shorter disease duration appear to be associated with improved compliance.

  • How this study might affect research, practice or policy

    • Self-reported compliance is highly unreliable and should be treated as such by practising clinicians and any future studies.

    • Among the patients with drop errors a small but clinically significant number have very poor compliance and miss drops daily. These patients are at high risk for sub-optimal disease control or persistent disease activity and this requires further investigation.

Synopsis/Precis This prospective study of drop compliance in children and young people with non-infectious uveitis suggests drop compliance is poor. Some individuals use drops less than half of the prescribed frequency. Self-reported compliance was highly unreliable.

Competing Interest Statement

Author Laura Steeples works for Roche Products UK Limited and has no conflict of interests in the findings of this study. All other authors confirm they have no competing interests.

Clinical Protocols

https://clinicaltrials.gov/ct2/show/NCT04148365

Funding Statement

We are grateful for funding from the British and Irish Paediatric Ophthalmology and Strabismus Association (BIPOSA). No author received payment or services from a third party for any aspect of the submitted work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval for this study was obtained from Health Research Authority, North East-Newcastle and North Tyneside 2 Research Ethics Committee according to the Declaration of Helsinki (REC reference 19/NE/0367). Participants gave informed consent to participate in the study before taking part. The study protocol was published on ClinicalTrials.gov (Identifier NCT04148365).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Orlaith.McGrath{at}mft.nhs.uk

  • Laura.Steeples{at}roche.com

  • Jane.Ashworth{at}mft.nhs.uk

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • Abbreviations

    PPR
    Person with parental responsibility
    JIA
    Juvenile idiopathic arthritis
    TINU
    Tubulointerstitial nephritis and uveitis
    CYP
    Child or young person
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted July 16, 2022.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Monitoring compliance to topical therapy in children and young people with uveitis
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Monitoring compliance to topical therapy in children and young people with uveitis
    EKY Green, O McGrath, L Steeples, J Ashworth
    medRxiv 2022.07.13.22277585; doi: https://doi.org/10.1101/2022.07.13.22277585
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Monitoring compliance to topical therapy in children and young people with uveitis
    EKY Green, O McGrath, L Steeples, J Ashworth
    medRxiv 2022.07.13.22277585; doi: https://doi.org/10.1101/2022.07.13.22277585

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Ophthalmology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)